Global and China Small Molecule Active Pharmaceutical Ingredient Market Insights, Forecast to 2026

Global and China Small Molecule Active Pharmaceutical Ingredient Market Insights, Forecast to 2026

Table of Contents
1 Study Coverage
1.1 Small Molecule Active Pharmaceutical Ingredient Product Introduction
1.2 Market Segments
1.3 Key Small Molecule Active Pharmaceutical Ingredient Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Small Molecule Active Pharmaceutical Ingredient Market Size Growth Rate by Type
1.4.2 Standard API
1.4.3 High Potency API
1.5 Market by Application
1.5.1 Global Small Molecule Active Pharmaceutical Ingredient Market Size Growth Rate by Application
1.5.2 Cardiovascular Diseases
1.5.3 Respiratory Disorders
1.5.4 Infectious Diseases
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Small Molecule Active Pharmaceutical Ingredient Market Size, Estimates and Forecasts
2.1.1 Global Small Molecule Active Pharmaceutical Ingredient Revenue 2015-2026
2.1.2 Global Small Molecule Active Pharmaceutical Ingredient Sales 2015-2026
2.2 Global Small Molecule Active Pharmaceutical Ingredient, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.3 Small Molecule Active Pharmaceutical Ingredient Historical Market Size by Region (2015-2020)
2.3.1 Global Small Molecule Active Pharmaceutical Ingredient Retrospective Market Scenario in Sales by Region: 2015-2020
2.3.2 Global Small Molecule Active Pharmaceutical Ingredient Retrospective Market Scenario in Revenue by Region: 2015-2020
2.4 Small Molecule Active Pharmaceutical Ingredient Market Estimates and Projections by Region (2021-2026)
2.4.1 Global Small Molecule Active Pharmaceutical Ingredient Sales Forecast by Region (2021-2026)
2.4.2 Global Small Molecule Active Pharmaceutical Ingredient Revenue Forecast by Region (2021-2026)
3 Global Small Molecule Active Pharmaceutical Ingredient Competitor Landscape by Players
3.1 Global Top Small Molecule Active Pharmaceutical Ingredient Sales by Manufacturers
3.1.1 Global Small Molecule Active Pharmaceutical Ingredient Sales by Manufacturers (2015-2020)
3.1.2 Global Small Molecule Active Pharmaceutical Ingredient Sales Market Share by Manufacturers (2015-2020)
3.2 Global Small Molecule Active Pharmaceutical Ingredient Manufacturers by Revenue
3.2.1 Global Small Molecule Active Pharmaceutical Ingredient Revenue by Manufacturers (2015-2020)
3.2.2 Global Small Molecule Active Pharmaceutical Ingredient Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Small Molecule Active Pharmaceutical Ingredient Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Small Molecule Active Pharmaceutical Ingredient Revenue in 2019
3.2.5 Global Small Molecule Active Pharmaceutical Ingredient Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Small Molecule Active Pharmaceutical Ingredient Price by Manufacturers
3.4 Global Small Molecule Active Pharmaceutical Ingredient Manufacturing Base Distribution, Product Types
3.4.1 Small Molecule Active Pharmaceutical Ingredient Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Small Molecule Active Pharmaceutical Ingredient Product Type
3.4.3 Date of International Manufacturers Enter into Small Molecule Active Pharmaceutical Ingredient Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Small Molecule Active Pharmaceutical Ingredient Market Size by Type (2015-2020)
4.1.1 Global Small Molecule Active Pharmaceutical Ingredient Sales by Type (2015-2020)
4.1.2 Global Small Molecule Active Pharmaceutical Ingredient Revenue by Type (2015-2020)
4.1.3 Small Molecule Active Pharmaceutical Ingredient Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Small Molecule Active Pharmaceutical Ingredient Market Size Forecast by Type (2021-2026)
4.2.1 Global Small Molecule Active Pharmaceutical Ingredient Sales Forecast by Type (2021-2026)
4.2.2 Global Small Molecule Active Pharmaceutical Ingredient Revenue Forecast by Type (2021-2026)
4.2.3 Small Molecule Active Pharmaceutical Ingredient Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Small Molecule Active Pharmaceutical Ingredient Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Small Molecule Active Pharmaceutical Ingredient Market Size by Application (2015-2020)
5.1.1 Global Small Molecule Active Pharmaceutical Ingredient Sales by Application (2015-2020)
5.1.2 Global Small Molecule Active Pharmaceutical Ingredient Revenue by Application (2015-2020)
5.1.3 Small Molecule Active Pharmaceutical Ingredient Price by Application (2015-2020)
5.2 Small Molecule Active Pharmaceutical Ingredient Market Size Forecast by Application (2021-2026)
5.2.1 Global Small Molecule Active Pharmaceutical Ingredient Sales Forecast by Application (2021-2026)
5.2.2 Global Small Molecule Active Pharmaceutical Ingredient Revenue Forecast by Application (2021-2026)
5.2.3 Global Small Molecule Active Pharmaceutical Ingredient Price Forecast by Application (2021-2026)
6 China by Players, Type and Application
6.1 China Small Molecule Active Pharmaceutical Ingredient Market Size YoY Growth 2015-2026
6.1.1 China Small Molecule Active Pharmaceutical Ingredient Sales YoY Growth 2015-2026
6.1.2 China Small Molecule Active Pharmaceutical Ingredient Revenue YoY Growth 2015-2026
6.1.3 China Small Molecule Active Pharmaceutical Ingredient Market Share in Global Market 2015-2026
6.2 China Small Molecule Active Pharmaceutical Ingredient Market Size by Players (International and Local Players)
6.2.1 China Top Small Molecule Active Pharmaceutical Ingredient Players by Sales (2015-2020)
6.2.2 China Top Small Molecule Active Pharmaceutical Ingredient Players by Revenue (2015-2020)
6.3 China Small Molecule Active Pharmaceutical Ingredient Historic Market Review by Type (2015-2020)
6.3.1 China Small Molecule Active Pharmaceutical Ingredient Sales Market Share by Type (2015-2020)
6.3.2 China Small Molecule Active Pharmaceutical Ingredient Revenue Market Share by Type (2015-2020)
6.3.3 China Small Molecule Active Pharmaceutical Ingredient Price by Type (2015-2020)
6.4 China Small Molecule Active Pharmaceutical Ingredient Market Estimates and Forecasts by Type (2021-2026)
6.4.1 China Small Molecule Active Pharmaceutical Ingredient Sales Forecast by Type (2021-2026)
6.4.2 China Small Molecule Active Pharmaceutical Ingredient Revenue Forecast by Type (2021-2026)
6.4.3 China Small Molecule Active Pharmaceutical Ingredient Price Forecast by Type (2021-2026)
6.5 China Small Molecule Active Pharmaceutical Ingredient Historic Market Review by Application (2015-2020)
6.5.1 China Small Molecule Active Pharmaceutical Ingredient Sales Market Share by Application (2015-2020)
6.5.2 China Small Molecule Active Pharmaceutical Ingredient Revenue Market Share by Application (2015-2020)
6.5.3 China Small Molecule Active Pharmaceutical Ingredient Price by Application (2015-2020)
6.6 China Small Molecule Active Pharmaceutical Ingredient Market Estimates and Forecasts by Application (2021-2026)
6.6.1 China Small Molecule Active Pharmaceutical Ingredient Sales Forecast by Application (2021-2026)
6.6.2 China Small Molecule Active Pharmaceutical Ingredient Revenue Forecast by Application (2021-2026)
6.6.3 China Small Molecule Active Pharmaceutical Ingredient Price Forecast by Application (2021-2026)
7 North America
7.1 North America Small Molecule Active Pharmaceutical Ingredient Market Size YoY Growth 2015-2026
7.2 North America Small Molecule Active Pharmaceutical Ingredient Market Facts & Figures by Country
7.2.1 North America Small Molecule Active Pharmaceutical Ingredient Sales by Country (2015-2020)
7.2.2 North America Small Molecule Active Pharmaceutical Ingredient Revenue by Country (2015-2020)
7.2.3 U.S.
7.2.4 Canada
8 Europe
8.1 Europe Small Molecule Active Pharmaceutical Ingredient Market Size YoY Growth 2015-2026
8.2 Europe Small Molecule Active Pharmaceutical Ingredient Market Facts & Figures by Country
8.2.1 Europe Small Molecule Active Pharmaceutical Ingredient Sales by Country
8.2.2 Europe Small Molecule Active Pharmaceutical Ingredient Revenue by Country
8.2.3 Germany
8.2.4 France
8.2.5 U.K.
8.2.6 Italy
8.2.7 Russia
9 Asia Pacific
9.1 Asia Pacific Small Molecule Active Pharmaceutical Ingredient Market Size YoY Growth 2015-2026
9.2 Asia Pacific Small Molecule Active Pharmaceutical Ingredient Market Facts & Figures by Country
9.2.1 Asia Pacific Small Molecule Active Pharmaceutical Ingredient Sales by Region (2015-2020)
9.2.2 Asia Pacific Small Molecule Active Pharmaceutical Ingredient Revenue by Region
9.2.3 China
9.2.4 Japan
9.2.5 South Korea
9.2.6 India
9.2.7 Australia
9.2.8 Taiwan
9.2.9 Indonesia
9.2.10 Thailand
9.2.11 Malaysia
9.2.12 Philippines
9.2.13 Vietnam
10 Latin America
10.1 Latin America Small Molecule Active Pharmaceutical Ingredient Market Size YoY Growth 2015-2026
10.2 Latin America Small Molecule Active Pharmaceutical Ingredient Market Facts & Figures by Country
10.2.1 Latin America Small Molecule Active Pharmaceutical Ingredient Sales by Country
10.2.2 Latin America Small Molecule Active Pharmaceutical Ingredient Revenue by Country
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Small Molecule Active Pharmaceutical Ingredient Market Size YoY Growth 2015-2026
11.2 Middle East and Africa Small Molecule Active Pharmaceutical Ingredient Market Facts & Figures by Country
11.2.1 Middle East and Africa Small Molecule Active Pharmaceutical Ingredient Sales by Country
11.2.2 Middle East and Africa Small Molecule Active Pharmaceutical Ingredient Revenue by Country
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E
12 Company Profiles
12.1 Johnson Matthey
12.1.1 Johnson Matthey Corporation Information
12.1.2 Johnson Matthey Description and Business Overview
12.1.3 Johnson Matthey Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Johnson Matthey Small Molecule Active Pharmaceutical Ingredient Products Offered
12.1.5 Johnson Matthey Recent Development
12.2 Siegfried Holding AG
12.2.1 Siegfried Holding AG Corporation Information
12.2.2 Siegfried Holding AG Description and Business Overview
12.2.3 Siegfried Holding AG Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Siegfried Holding AG Small Molecule Active Pharmaceutical Ingredient Products Offered
12.2.5 Siegfried Holding AG Recent Development
12.3 Pfizer
12.3.1 Pfizer Corporation Information
12.3.2 Pfizer Description and Business Overview
12.3.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Pfizer Small Molecule Active Pharmaceutical Ingredient Products Offered
12.3.5 Pfizer Recent Development
12.4 Sanofi S.A.
12.4.1 Sanofi S.A. Corporation Information
12.4.2 Sanofi S.A. Description and Business Overview
12.4.3 Sanofi S.A. Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Sanofi S.A. Small Molecule Active Pharmaceutical Ingredient Products Offered
12.4.5 Sanofi S.A. Recent Development
12.5 Novartis AG,
12.5.1 Novartis AG, Corporation Information
12.5.2 Novartis AG, Description and Business Overview
12.5.3 Novartis AG, Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Novartis AG, Small Molecule Active Pharmaceutical Ingredient Products Offered
12.5.5 Novartis AG, Recent Development
12.6 Bristol-Myers Squibb
12.6.1 Bristol-Myers Squibb Corporation Information
12.6.2 Bristol-Myers Squibb Description and Business Overview
12.6.3 Bristol-Myers Squibb Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Bristol-Myers Squibb Small Molecule Active Pharmaceutical Ingredient Products Offered
12.6.5 Bristol-Myers Squibb Recent Development
12.7 Boehringer Ingelheim GmbH
12.7.1 Boehringer Ingelheim GmbH Corporation Information
12.7.2 Boehringer Ingelheim GmbH Description and Business Overview
12.7.3 Boehringer Ingelheim GmbH Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Boehringer Ingelheim GmbH Small Molecule Active Pharmaceutical Ingredient Products Offered
12.7.5 Boehringer Ingelheim GmbH Recent Development
12.8 GlaxoSmithKline
12.8.1 GlaxoSmithKline Corporation Information
12.8.2 GlaxoSmithKline Description and Business Overview
12.8.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
12.8.4 GlaxoSmithKline Small Molecule Active Pharmaceutical Ingredient Products Offered
12.8.5 GlaxoSmithKline Recent Development
12.9 Albany Molecular Research Inc.
12.9.1 Albany Molecular Research Inc. Corporation Information
12.9.2 Albany Molecular Research Inc. Description and Business Overview
12.9.3 Albany Molecular Research Inc. Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Albany Molecular Research Inc. Small Molecule Active Pharmaceutical Ingredient Products Offered
12.9.5 Albany Molecular Research Inc. Recent Development
12.10 Bachem Holding AG
12.10.1 Bachem Holding AG Corporation Information
12.10.2 Bachem Holding AG Description and Business Overview
12.10.3 Bachem Holding AG Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Bachem Holding AG Small Molecule Active Pharmaceutical Ingredient Products Offered
12.10.5 Bachem Holding AG Recent Development
12.11 Johnson Matthey
12.11.1 Johnson Matthey Corporation Information
12.11.2 Johnson Matthey Description and Business Overview
12.11.3 Johnson Matthey Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Johnson Matthey Small Molecule Active Pharmaceutical Ingredient Products Offered
12.11.5 Johnson Matthey Recent Development
12.12 Patheon N.V.
12.12.1 Patheon N.V. Corporation Information
12.12.2 Patheon N.V. Description and Business Overview
12.12.3 Patheon N.V. Sales, Revenue and Gross Margin (2015-2020)
12.12.4 Patheon N.V. Products Offered
12.12.5 Patheon N.V. Recent Development
12.13 AstraZeneca
12.13.1 AstraZeneca Corporation Information
12.13.2 AstraZeneca Description and Business Overview
12.13.3 AstraZeneca Sales, Revenue and Gross Margin (2015-2020)
12.13.4 AstraZeneca Products Offered
12.13.5 AstraZeneca Recent Development
12.14 Johnson & Johnson
12.14.1 Johnson & Johnson Corporation Information
12.14.2 Johnson & Johnson Description and Business Overview
12.14.3 Johnson & Johnson Sales, Revenue and Gross Margin (2015-2020)
12.14.4 Johnson & Johnson Products Offered
12.14.5 Johnson & Johnson Recent Development
12.15 Merck & Co
12.15.1 Merck & Co Corporation Information
12.15.2 Merck & Co Description and Business Overview
12.15.3 Merck & Co Sales, Revenue and Gross Margin (2015-2020)
12.15.4 Merck & Co Products Offered
12.15.5 Merck & Co Recent Development
12.16 BASF SE
12.16.1 BASF SE Corporation Information
12.16.2 BASF SE Description and Business Overview
12.16.3 BASF SE Sales, Revenue and Gross Margin (2015-2020)
12.16.4 BASF SE Products Offered
12.16.5 BASF SE Recent Development
12.17 Catalent Inc.
12.17.1 Catalent Inc. Corporation Information
12.17.2 Catalent Inc. Description and Business Overview
12.17.3 Catalent Inc. Sales, Revenue and Gross Margin (2015-2020)
12.17.4 Catalent Inc. Products Offered
12.17.5 Catalent Inc. Recent Development
12.18 Teva Pharmaceuticals
12.18.1 Teva Pharmaceuticals Corporation Information
12.18.2 Teva Pharmaceuticals Description and Business Overview
12.18.3 Teva Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
12.18.4 Teva Pharmaceuticals Products Offered
12.18.5 Teva Pharmaceuticals Recent Development
12.19 Roche
12.19.1 Roche Corporation Information
12.19.2 Roche Description and Business Overview
12.19.3 Roche Sales, Revenue and Gross Margin (2015-2020)
12.19.4 Roche Products Offered
12.19.5 Roche Recent Development
12.20 Cambrex Corporation
12.20.1 Cambrex Corporation Corporation Information
12.20.2 Cambrex Corporation Description and Business Overview
12.20.3 Cambrex Corporation Sales, Revenue and Gross Margin (2015-2020)
12.20.4 Cambrex Corporation Products Offered
12.20.5 Cambrex Corporation Recent Development
12.21 GILEAD Science Inc.
12.21.1 GILEAD Science Inc. Corporation Information
12.21.2 GILEAD Science Inc. Description and Business Overview
12.21.3 GILEAD Science Inc. Sales, Revenue and Gross Margin (2015-2020)
12.21.4 GILEAD Science Inc. Products Offered
12.21.5 GILEAD Science Inc. Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter's Five Forces Analysis
13.5 Primary Interviews with Key Small Molecule Active Pharmaceutical Ingredient Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Small Molecule Active Pharmaceutical Ingredient Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Small Molecule Active Pharmaceutical Ingredient Market Segments
Table 2. Ranking of Global Top Small Molecule Active Pharmaceutical Ingredient Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Small Molecule Active Pharmaceutical Ingredient Market Size Growth Rate by Type 2020-2026 (MT) & (US$ Million)
Table 4. Major Manufacturers of Standard API
Table 5. Major Manufacturers of High Potency API
Table 6. Global Small Molecule Active Pharmaceutical Ingredient Market Size Growth Rate by Application 2020-2026 (MT)
Table 7. Global Small Molecule Active Pharmaceutical Ingredient Market Size by Region (MT) & (US$ Million): 2020 VS 2026
Table 8. Global Small Molecule Active Pharmaceutical Ingredient Sales by Regions 2015-2020 (MT)
Table 9. Global Small Molecule Active Pharmaceutical Ingredient Sales Market Share by Regions (2015-2020)
Table 10. Global Small Molecule Active Pharmaceutical Ingredient Revenue by Regions 2015-2020 (US$ Million)
Table 11. Global Small Molecule Active Pharmaceutical Ingredient Sales Forecast by Region (2021-2026) (MT)
Table 12. Global Small Molecule Active Pharmaceutical Ingredient Sales by Manufacturers (2015-2020) (MT)
Table 13. Global Small Molecule Active Pharmaceutical Ingredient Sales Share by Manufacturers (2015-2020)
Table 14. Global Small Molecule Active Pharmaceutical Ingredient Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 15. Global Small Molecule Active Pharmaceutical Ingredient by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Small Molecule Active Pharmaceutical Ingredient as of 2019)
Table 16. Small Molecule Active Pharmaceutical Ingredient Revenue by Manufacturers (2015-2020) (US$ Million)
Table 17. Small Molecule Active Pharmaceutical Ingredient Revenue Share by Manufacturers (2015-2020)
Table 18. Key Manufacturers Small Molecule Active Pharmaceutical Ingredient Price (2015-2020) (USD/MT)
Table 19. Small Molecule Active Pharmaceutical Ingredient Manufacturers Manufacturing Base Distribution and Headquarters
Table 20. Manufacturers Small Molecule Active Pharmaceutical Ingredient Product Type
Table 21. Date of International Manufacturers Enter into Small Molecule Active Pharmaceutical Ingredient Market
Table 22. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 23. Global Small Molecule Active Pharmaceutical Ingredient Sales by Type (2015-2020) (MT)
Table 24. Global Small Molecule Active Pharmaceutical Ingredient Sales Share by Type (2015-2020)
Table 25. Global Small Molecule Active Pharmaceutical Ingredient Revenue by Type (2015-2020) (US$ Million)
Table 26. Global Small Molecule Active Pharmaceutical Ingredient Revenue Share by Type (2015-2020)
Table 27. Small Molecule Active Pharmaceutical Ingredient Average Selling Price (ASP) by Type 2015-2020 (USD/MT)
Table 28. Global Small Molecule Active Pharmaceutical Ingredient Sales Share by Type (2021-2026)
Table 29. Global Small Molecule Active Pharmaceutical Ingredient Sales by Application (2015-2020) (MT)
Table 30. Global Small Molecule Active Pharmaceutical Ingredient Sales Share by Application (2015-2020)
Table 31. Global Small Molecule Active Pharmaceutical Ingredient Sales Share by Application (2021-2026)
Table 32. Global Small Molecule Active Pharmaceutical Ingredient Sales Market Share Forecast by Application (2021-2026)
Table 33. Global Small Molecule Active Pharmaceutical Ingredient Revenue by Application (2015-2020) (US$ Million)
Table 34. Global Small Molecule Active Pharmaceutical Ingredient Revenue Market Share Forecast by Application (2021-2026)
Table 35. China Small Molecule Active Pharmaceutical Ingredient Sales (MT) of Key Companies (2015-2020)
Table 36. China Small Molecule Active Pharmaceutical Ingredient Sales Share by Company (2015-2020)
Table 37. China Small Molecule Active Pharmaceutical Ingredient Revenue (US$ Million) by Company (2015-2020)
Table 38. China Small Molecule Active Pharmaceutical Ingredient Sales (MT) by Type (2015-2020)
Table 39. China Small Molecule Active Pharmaceutical Ingredient Sales Share by Type (2015-2020)
Table 40. China Small Molecule Active Pharmaceutical Ingredient Revenue (US$ Million) Market Share by Type (2015-2020)
Table 41. China Small Molecule Active Pharmaceutical Ingredient Price (MT) by Type (2015-2020)
Table 42. China Small Molecule Active Pharmaceutical Ingredient Sales (MT) by Type (2021-2026)
Table 43. China Small Molecule Active Pharmaceutical Ingredient Sales Share by Type (2021-2026)
Table 44. China Small Molecule Active Pharmaceutical Ingredient Revenue (US$ Million) Market Share by Type (2021-2026)
Table 45. China Small Molecule Active Pharmaceutical Ingredient Revenue Share by Type (2021-2026)
Table 46. China Small Molecule Active Pharmaceutical Ingredient Price (MT) by Type (2021-2026)
Table 47. China Small Molecule Active Pharmaceutical Ingredient Sales (MT) by Application (2015-2020)
Table 48. China Small Molecule Active Pharmaceutical Ingredient Sales Share by Application (2015-2020)
Table 49. China Small Molecule Active Pharmaceutical Ingredient Revenue (US$ Million) Market Share by Application (2015-2020)
Table 50. China Small Molecule Active Pharmaceutical Ingredient Sales (MT) by Application (2021-2026)
Table 51. China Small Molecule Active Pharmaceutical Ingredient Sales Share by Application (2021-2026)
Table 52. China Small Molecule Active Pharmaceutical Ingredient Revenue (US$ Million) Market Share by Application (2021-2026)
Table 53. China Small Molecule Active Pharmaceutical Ingredient Revenue Share by Application (2021-2026)
Table 54. North America Small Molecule Active Pharmaceutical Ingredient Sales by Country (2015-2020) (MT)
Table 55. North America Small Molecule Active Pharmaceutical Ingredient Sales Market Share by Country (2015-2020)
Table 56. North America Small Molecule Active Pharmaceutical Ingredient Revenue by Country (2015-2020) (US$ Million)
Table 57. North America Small Molecule Active Pharmaceutical Ingredient Revenue Market Share by Country (2015-2020)
Table 58. Europe Small Molecule Active Pharmaceutical Ingredient Sales by Country (2015-2020) (MT)
Table 59. Europe Small Molecule Active Pharmaceutical Ingredient Sales Market Share by Country (2015-2020)
Table 60. Europe Small Molecule Active Pharmaceutical Ingredient Revenue by Country (2015-2020) (US$ Million)
Table 61. Europe Small Molecule Active Pharmaceutical Ingredient Revenue Market Share by Country (2015-2020)
Table 62. Asia Pacific Small Molecule Active Pharmaceutical Ingredient Sales by Region (2015-2020) (MT)
Table 63. Asia Pacific Small Molecule Active Pharmaceutical Ingredient Sales Market Share by Region (2015-2020)
Table 64. Asia Pacific Small Molecule Active Pharmaceutical Ingredient Revenue by Region (2015-2020) (US$ Million)
Table 65. Asia Pacific Small Molecule Active Pharmaceutical Ingredient Revenue Market Share by Region (2015-2020)
Table 66. Latin America Small Molecule Active Pharmaceutical Ingredient Sales by Country (2015-2020) (MT)
Table 67. Latin America Small Molecule Active Pharmaceutical Ingredient Sales Market Share by Country (2015-2020)
Table 68. Latin Americaa Small Molecule Active Pharmaceutical Ingredient Revenue by Country (2015-2020) (US$ Million)
Table 69. Latin America Small Molecule Active Pharmaceutical Ingredient Revenue Market Share by Country (2015-2020)
Table 70. Middle East and Africa Small Molecule Active Pharmaceutical Ingredient Sales by Country (2015-2020) (MT)
Table 71. Middle East and Africa Small Molecule Active Pharmaceutical Ingredient Sales Market Share by Country (2015-2020)
Table 72. Middle East and Africa Small Molecule Active Pharmaceutical Ingredient Revenue by Country (2015-2020) (US$ Million)
Table 73. Middle East and Africa Small Molecule Active Pharmaceutical Ingredient Revenue Market Share by Country (2015-2020)
Table 74. Johnson Matthey Corporation Information
Table 75. Johnson Matthey Description and Business Overview
Table 76. Johnson Matthey Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 77. Johnson Matthey Small Molecule Active Pharmaceutical Ingredient Product
Table 78. Johnson Matthey Recent Development
Table 79. Siegfried Holding AG Corporation Information
Table 80. Siegfried Holding AG Description and Business Overview
Table 81. Siegfried Holding AG Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 82. Siegfried Holding AG Product
Table 83. Siegfried Holding AG Recent Development
Table 84. Pfizer Corporation Information
Table 85. Pfizer Description and Business Overview
Table 86. Pfizer Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 87. Pfizer Product
Table 88. Pfizer Recent Development
Table 89. Sanofi S.A. Corporation Information
Table 90. Sanofi S.A. Description and Business Overview
Table 91. Sanofi S.A. Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 92. Sanofi S.A. Product
Table 93. Sanofi S.A. Recent Development
Table 94. Novartis AG, Corporation Information
Table 95. Novartis AG, Description and Business Overview
Table 96. Novartis AG, Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 97. Novartis AG, Product
Table 98. Novartis AG, Recent Development
Table 99. Bristol-Myers Squibb Corporation Information
Table 100. Bristol-Myers Squibb Description and Business Overview
Table 101. Bristol-Myers Squibb Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 102. Bristol-Myers Squibb Product
Table 103. Bristol-Myers Squibb Recent Development
Table 104. Boehringer Ingelheim GmbH Corporation Information
Table 105. Boehringer Ingelheim GmbH Description and Business Overview
Table 106. Boehringer Ingelheim GmbH Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 107. Boehringer Ingelheim GmbH Product
Table 108. Boehringer Ingelheim GmbH Recent Development
Table 109. GlaxoSmithKline Corporation Information
Table 110. GlaxoSmithKline Description and Business Overview
Table 111. GlaxoSmithKline Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 112. GlaxoSmithKline Product
Table 113. GlaxoSmithKline Recent Development
Table 114. Albany Molecular Research Inc. Corporation Information
Table 115. Albany Molecular Research Inc. Description and Business Overview
Table 116. Albany Molecular Research Inc. Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 117. Albany Molecular Research Inc. Product
Table 118. Albany Molecular Research Inc. Recent Development
Table 119. Bachem Holding AG Corporation Information
Table 120. Bachem Holding AG Description and Business Overview
Table 121. Bachem Holding AG Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 122. Bachem Holding AG Product
Table 123. Bachem Holding AG Recent Development
Table 124. PCAS Corporation Information
Table 125. PCAS Description and Business Overview
Table 126. PCAS Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 127. PCAS Product
Table 128. PCAS Recent Development
Table 129. Patheon N.V. Corporation Information
Table 130. Patheon N.V. Description and Business Overview
Table 131. Patheon N.V. Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 132. Patheon N.V. Product
Table 133. Patheon N.V. Recent Development
Table 134. AstraZeneca Corporation Information
Table 135. AstraZeneca Description and Business Overview
Table 136. AstraZeneca Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 137. AstraZeneca Product
Table 138. AstraZeneca Recent Development
Table 139. Johnson & Johnson Corporation Information
Table 140. Johnson & Johnson Description and Business Overview
Table 141. Johnson & Johnson Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 142. Johnson & Johnson Product
Table 143. Johnson & Johnson Recent Development
Table 144. Merck & Co Corporation Information
Table 145. Merck & Co Description and Business Overview
Table 146. Merck & Co Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 147. Merck & Co Product
Table 148. Merck & Co Recent Development
Table 149. BASF SE Corporation Information
Table 150. BASF SE Description and Business Overview
Table 151. BASF SE Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 152. BASF SE Product
Table 153. BASF SE Recent Development
Table 154. Catalent Inc. Corporation Information
Table 155. Catalent Inc. Description and Business Overview
Table 156. Catalent Inc. Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 157. Catalent Inc. Product
Table 158. Catalent Inc. Recent Development
Table 159. Teva Pharmaceuticals Corporation Information
Table 160. Teva Pharmaceuticals Description and Business Overview
Table 161. Teva Pharmaceuticals Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 162. Teva Pharmaceuticals Product
Table 163. Teva Pharmaceuticals Recent Development
Table 164. Roche Corporation Information
Table 165. Roche Description and Business Overview
Table 166. Roche Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 167. Roche Product
Table 168. Roche Recent Development
Table 169. Cambrex Corporation Corporation Information
Table 170. Cambrex Corporation Description and Business Overview
Table 171. Cambrex Corporation Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 172. Cambrex Corporation Product
Table 173. Cambrex Corporation Recent Development
Table 174. GILEAD Science Inc. Corporation Information
Table 175. GILEAD Science Inc. D

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs